Moleculent AB raised $26 million in a Series A financing led by ARCH Venture Partners and co-led by Eir Ventures to advance the spatial mapping of cell-cell communication.
Amount Raised
$26 Million
Round Type
Series A
StockholmBiotechnologyHealth CareInvestors
Description
Moleculent AB, a company pioneering technology to study the communication between cells in human tissue, closed an oversubscribed $26 million Series A financing. The round was led by ARCH Venture Partners and co-led by Eir Ventures with participation from the company’s existing investors.
Quick answer
Moleculent AB raised $26 Million in a Series A round, dated June 11, 2024. Investors: Eir Ventures and ARCH Venture Partners. Moleculent AB is based in Stockholm, Stockholm County, Sweden.
- How much did Moleculent AB raise?
- Moleculent AB raised $26 Million in a Series A round on June 11, 2024.
- Who invested in Moleculent AB?
- Eir Ventures and ARCH Venture Partners are named as investors in this round.
- What does Moleculent AB do?
- Moleculent is a company on a mission to develop advanced technology-enabled products that leverage new insights into the molecular foundation of human biology.
- Where is Moleculent AB based and how big is it?
- Moleculent AB is based in Stockholm, Stockholm County, Sweden. Fundz records about 64 employees.
- Who are the decision-makers at Moleculent AB?
- Fundz holds 2 contacts at Moleculent AB, including the Founder and CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Moleculent AB that raised within 45 days of this round, from Fundz verified event records.
- 4D Medicine raised $4.4M (Series A) on July 26, 2024.
- Amporin Pharmaceuticals raised $170K (Grant) on July 26, 2024.
- JaxBio Technologies raised $2.7M (Grant) on July 24, 2024.
- PK MED raised $1.6M (Grant) on July 24, 2024.
- Autobahn Therapeutics raised $100M (Series C) on July 24, 2024.
- Osheru raised $4.7M (Seed) on July 24, 2024.
Who to call at Moleculent AB, and when
A new round usually means Moleculent AB is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Moleculent AB raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Moleculent AB, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Moleculent AB. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Moleculent AB raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMoleculent AB raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.